Published by
@ShahidNShah
@ShahidNShah
Digital health companies should stay away from FDA in 2021
Posted via mobihealthnews.comAs the agency's workload swells with the weight of a public health emergency, digital health companies on a timeline should consider whether their products truly warrant a regulatory submission, writes Epstein Becker & Green's Bradley Merrill Thompson.
Healthcare IT News: Digital Health
U.S. Food and Drug Administration (FDA): Medical Device Interoperability
See Also
- Rising Risks to Patient Data and HIPAA Compliance in the Age of COVID-19
- Keeping Your Head Above Water in a Wave of Medical Data With Technology and Managerial Expertise
- The Health System of the Future Will Be Consumer-Centric, Wellness-Oriented and Digitally Connected
- Why Home Healthcare Needs More Technology and Training
- Digital Mental Health on the Rise, but Engagement, Access and Trust Continue to Be Barriers
Next Article
Our Favourite Digital Health Articles Of 2020
We strongly believe that only digital health can bring healthcare into the 21st century and make patients the point-of-care. Yes, it’s THAT time of the year and it’s always good to look back at the …
Medigy Innovation Network
Connecting innovation decision makers to authoritative information, institutions, people and insights.
© 2021 Netspective Media LLC. All Rights Reserved.
Built on Feb 24, 2021 at 7:39am
Built on Feb 24, 2021 at 7:39am
